Omeros Corporation
OMER
#6443
Rank
A$1.15 B
Marketcap
A$16.33
Share price
-1.63%
Change (1 day)
-5.08%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -A$0.2 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.24 Billion a decrease over its 2023 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.2 Billion-17.95%
2024 -A$0.24 Billion9.63%
2023 -A$0.22 Billion-9.57%
2022 -A$0.24 Billion-30.65%
2021 -A$0.35 Billion86.28%
2020 -A$0.19 Billion99.45%
2019 -A$93.09 Million-49.91%
2018 -A$0.19 Billion190.77%
2017 -A$63.91 Million-27.96%
2016 -A$88.72 Million-17.61%
2015 -A$0.11 Billion1.88%
2014 -A$0.11 Billion87.56%
2013 -A$56.36 Million
2011 -A$41.27 Million-8.96%
2010 -A$45.33 Million45.03%
2009 -A$31.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-A$14.29 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-A$5.82 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
A$17.84 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA